Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Lin

Showing results (111-120 of 328) with videos related to

Pageof 33
Sort By:
Molecular Oncology|June 6, 2009
Characterizing DNA methylation patterns in pancreatic cancer genomeAik Choon Tan, Antonio Jimeno, Steven H Lin, et al.
Journal for Immunotherapy of Cancer|March 14, 2024
BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1Young-Seung Kim, Seung-Hoon Lee, Andrew H Park, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Re-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinomaLiru He, Pamela K Allen, Adam Potter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapyWei Deng, Cai Xu, Amy Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Wee1 Kinase Inhibitor AZD1775 Effectively Sensitizes Esophageal Cancer to RadiotherapyLinlin Yang, Changxian Shen, Cory J Pettit, et al.
Annals of Surgical Oncology|September 9, 2018
Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveillance StrategiesSha Zhou, Shiliang Liu, Li Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2024
Personalized Composite Dosimetric Score-Based Machine Learning Model of Severe Radiation-Induced Lymphopenia Among Patients With Esophageal CancerYan Chu, Cong Zhu, Brian P Hobbs, et al.
Translational Lung Cancer Research|November 19, 2020
Enumeration and molecular characterization of circulating tumor cells enriched by microcavity array from stage III non-small cell lung cancer patientsEvan N Cohen, Gitanjali Jayachandran, Hui Gao, et al.
Advances in Radiation Oncology|March 5, 2021
Patient-Specific Lymphocyte Loss Kinetics as Biomarker of Spleen Dose in Patients Undergoing Radiation Therapy for Upper Abdominal MalignanciesAnirudh Yalamanchali, Hong Zhang, Ke Colin Huang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2015
Comparison of locoregional versus extended locoregional radiation volumes for patients with nonmetastatic gastro-esophageal junction carcinomasJingya Wang, Denái R Milton, Liru He, et al.
Pageof 33

Showing results (111-120 of 328) with videos related to

Sort By:
Pageof 33
Molecular Oncology|June 6, 2009
Characterizing DNA methylation patterns in pancreatic cancer genomeAik Choon Tan, Antonio Jimeno, Steven H Lin, et al.
Journal for Immunotherapy of Cancer|March 14, 2024
BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1Young-Seung Kim, Seung-Hoon Lee, Andrew H Park, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Re-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinomaLiru He, Pamela K Allen, Adam Potter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapyWei Deng, Cai Xu, Amy Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Wee1 Kinase Inhibitor AZD1775 Effectively Sensitizes Esophageal Cancer to RadiotherapyLinlin Yang, Changxian Shen, Cory J Pettit, et al.
Annals of Surgical Oncology|September 9, 2018
Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveillance StrategiesSha Zhou, Shiliang Liu, Li Zhang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2024
Personalized Composite Dosimetric Score-Based Machine Learning Model of Severe Radiation-Induced Lymphopenia Among Patients With Esophageal CancerYan Chu, Cong Zhu, Brian P Hobbs, et al.
Translational Lung Cancer Research|November 19, 2020
Enumeration and molecular characterization of circulating tumor cells enriched by microcavity array from stage III non-small cell lung cancer patientsEvan N Cohen, Gitanjali Jayachandran, Hui Gao, et al.
Advances in Radiation Oncology|March 5, 2021
Patient-Specific Lymphocyte Loss Kinetics as Biomarker of Spleen Dose in Patients Undergoing Radiation Therapy for Upper Abdominal MalignanciesAnirudh Yalamanchali, Hong Zhang, Ke Colin Huang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2015
Comparison of locoregional versus extended locoregional radiation volumes for patients with nonmetastatic gastro-esophageal junction carcinomasJingya Wang, Denái R Milton, Liru He, et al.
Pageof 33